Investigating retinal damage in COVID-19 patients using non-invasive imaging
Official title: COVID-19 Patient Cohort: Retinal Damage in Non-invasive Retinal Imaging (OCTA)
Run by Centre Hospitalier Intercommunal Creteil · NCT04881253 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing if COVID-19 can cause damage to the eyes by using special imaging techniques on patients with different levels of illness.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Centre Hospitalier Intercommunal Creteil Academic / other |
| Locations | 1 site (Créteil, IDF) |
| Trial ID | NCT04881253 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who have been diagnosed with COVID-19.
✕Probably not a fit
Patients who do not have a confirmed diagnosis of COVID-19 or those who refuse to participate will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to collect non-invasive retinal imaging data, specifically using optical coherence tomography (OCT) and OCT angiography (OCTA), to assess the incidence and impact of retinal damage in patients with COVID-19. It includes three groups of participants: those hospitalized for COVID-19, newly diagnosed patients, and those with mild symptoms who did not require hospitalization. An ophthalmologic assessment will be conducted at inclusion, which includes visual acuity tests and various imaging techniques to detect potential retinal lesions. The study seeks to correlate clinical parameters with retinal vascular damage to enhance understanding of the disease's pathophysiology.
Why it matters
Potential benefit: If successful, this study could provide insights into the retinal complications associated with COVID-19, potentially leading to better management and treatment strategies for affected patients.
How similar studies have gone: While this study focuses on a specific aspect of COVID-19, similar studies investigating retinal damage in other conditions have shown promising results, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years old * Diagnosis of COVID-19 proven on RT-PCR, antigenic test or chest CT scan * Affiliation to the general social security system * A consent signed by the patient Exclusion Criteria: - Refusal of patient participation
Where it's running
-
Centre Hospitalier Intercommunal de Créteil
Créteil, Idf, France Recruiting
Study contacts
- Study coordinator: Camille JUNG, MD
- Email: camille.jung@chicreteil.fr
- Phone: 01 45 17 50 00
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating olfactory dysfunction after COVID-19 infection
This study is trying to understand why some people still have trouble smelling after recovering from COVID-19 by looking at samples from their noses.
-
Registry to evaluate pregnancy outcomes in women treated for COVID-19
This study is trying to see how treatments for COVID-19, like certain medications, affect the health of pregnant women and their babies.
-
Collecting COVID-19 virus secretions and serum for developing treatments
This study is collecting samples from people with COVID-19 to learn more about how the virus behaves and how it affects recovery, with the goal of improving treatments for those at higher risk.
-
Using donor-derived T cells to treat mild to moderate COVID-19
This study is testing whether T cells from family members who have recovered from COVID-19 can help treat hospitalized patients with mild to moderate COVID-19.
-
Observational study on the biology of COVID-19 in Saarland
This study looks at how COVID-19 affects people in different ways, including those with long-term symptoms, to learn more about the disease and its progression.
-
Imaging immune activation in COVID-19 patients
This study is testing a special imaging technique to see how the immune system is working in people who have recently recovered from COVID-19.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.